These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 29357856)

  • 21. A neural mechanism of direct and observational conditioning for placebo and nocebo responses.
    Tu Y; Park J; Ahlfors SP; Khan S; Egorova N; Lang C; Cao J; Kong J
    Neuroimage; 2019 Jan; 184():954-963. PubMed ID: 30296557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Placebo and nocebo : How can they be used or avoided?].
    Hansen E; Zech N; Meissner K
    Internist (Berl); 2017 Oct; 58(10):1102-1110. PubMed ID: 28702702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neglect of sex: A call to action for including sex as a biological variable in placebo and nocebo research.
    Shafir R; Olson E; Colloca L
    Contemp Clin Trials; 2022 May; 116():106734. PubMed ID: 35306216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Nocebo Effect.
    Colloca L
    Annu Rev Pharmacol Toxicol; 2024 Jan; 64():171-190. PubMed ID: 37585661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Placebo and nocebo effects on itch : Methodological and clinical implications].
    Tekampe J; Peerdeman KJ; Bartels DJP; van Laarhoven AIM; Evers AWM
    Hautarzt; 2018 Aug; 69(8):626-630. PubMed ID: 29947820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment Outcomes.
    Chavarria V; Vian J; Pereira C; Data-Franco J; Fernandes BS; Berk M; Dodd S
    Clin Ther; 2017 Mar; 39(3):477-486. PubMed ID: 28237673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Review of the Theoretical and Biological Understanding of the Nocebo and Placebo Phenomena.
    Dodd S; Dean OM; Vian J; Berk M
    Clin Ther; 2017 Mar; 39(3):469-476. PubMed ID: 28161116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can a Brief Relaxation Exercise Modulate Placebo or Nocebo Effects in a Visceral Pain Model?
    Elsenbruch S; Roderigo T; Enck P; Benson S
    Front Psychiatry; 2019; 10():144. PubMed ID: 30949080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pain Modulation: From Conditioned Pain Modulation to Placebo and Nocebo Effects in Experimental and Clinical Pain.
    Damien J; Colloca L; Bellei-Rodriguez CÉ; Marchand S
    Int Rev Neurobiol; 2018; 139():255-296. PubMed ID: 30146050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Role of Placebo: Evolution of a New Paradigm in Understanding Research and Clinical Practice.
    Manchikanti L; Boswell MV; Kaye AD; Helm Ii S; Hirsch JA
    Pain Physician; 2017 Jul; 20(5):363-386. PubMed ID: 28727700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The awareness of contextual factors, placebo and nocebo effects among nursing students: Findings from a cross-sectional study.
    Cadorin L; Rossettini G; Testa M; Geri T; Palese A
    Nurse Educ Pract; 2020 Jan; 42():102670. PubMed ID: 31775083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placebo and nocebo in interventional pain management: a friend or a foe--or simply foes?
    Manchikanti L; Giordano J; Fellows B; Hirsch JA
    Pain Physician; 2011; 14(2):E157-75. PubMed ID: 21412379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Biology of Placebo and Nocebo Effects on Experimental and Chronic Pain: State of the Art.
    Rossettini G; Campaci F; Bialosky J; Huysmans E; Vase L; Carlino E
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classical conditioning without verbal suggestions elicits placebo analgesia and nocebo hyperalgesia.
    Bąbel P; Bajcar EA; Adamczyk W; Kicman P; Lisińska N; Świder K; Colloca L
    PLoS One; 2017; 12(7):e0181856. PubMed ID: 28750001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Oxytocin on Placebo and Nocebo Effects in a Pain Conditioning Paradigm: A Randomized Controlled Trial.
    Skvortsova A; Veldhuijzen DS; van Middendorp H; Colloca L; Evers AWM
    J Pain; 2020; 21(3-4):430-439. PubMed ID: 31494273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of open-label counterconditioning for reducing nocebo effects on pressure pain.
    Meijer S; Karacaoglu M; van Middendorp H; Veldhuijzen DS; Jensen KB; Peerdeman KJ; Evers AWM
    Eur J Pain; 2023 Aug; 27(7):831-847. PubMed ID: 36932915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European Headache Federation recommendations for placebo and nocebo terminology.
    Mitsikostas DD; Blease C; Carlino E; Colloca L; Geers AL; Howick J; Evers AWM; Flaten MA; Kelley JM; Kirsch I; Klinger R; MaassenVanDenBrink A; Moerman DE; Sfikakis PP; Vase L; Wager TD; Benedetti F;
    J Headache Pain; 2020 Sep; 21(1):117. PubMed ID: 32977761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Placebo Nocebo Ethics in Communicating with Patients How Anaesthesiologists Should Handle the Psychosomatic Dimension of Briefing].
    Friedrich DR; Reichardt JO; Rittner HL
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Sep; 53(9):592-604. PubMed ID: 30176687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Placebo and nocebo effects in randomized controlled trials: the implications for research and practice.
    Sanderson C; Hardy J; Spruyt O; Currow DC
    J Pain Symptom Manage; 2013 Nov; 46(5):722-30. PubMed ID: 23523360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placebo and nocebo in cardiovascular health: implications for healthcare, research, and the doctor-patient relationship.
    Olshansky B
    J Am Coll Cardiol; 2007 Jan; 49(4):415-21. PubMed ID: 17258086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.